Colomiralin

N/A

Report date: 2025/01/15 20:00:32

NME

Base Information

Drug NameColomiralin

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsColonic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMicrolin Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMicrolin Bio Inc

Active IndicationsN/A

Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A